Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 18 November 2017

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Lethal hospital bug cases rocket

A new strain of C. difficile is difficult to eradicate from the ward, causing an excess number of cases, as well as more severe cases that make patients very ill, reports the BBC.

News image

fiogf49gjkf04

Clostridium difficile is not resistant to treatment, but some cases are difficult to treat.

The strain seen at Stoke Mandeville hospital in England is related to one which has emerged in the USA and Canada.

The number of cases of a potentially lethal hospital infection has rocketed since the 1990s, figures show.

The Department of Health has revealed there were 44,488 cases of C. difficile in over 65s in England last year.

The BBC News reports that this was the first time mandatory surveillance of the diarrhoea-causing infection has been undertaken.

In the early 1990s there were about 1,000 cases a year, but by 2003 the total rose to 35,536, England, Wales and Northern Ireland data showed.

However, this was only collected on a voluntary basis so the true figure may have been higher.

These latest statistics have showed that C.difficile is nearly 7 times more common than MRSA, although the superbug is more deadly.

C. difficile cannot be destroyed by hand gels, whereas MRSA can
BBC News

The Office for National Statistics data has showed C.difficile was the underlying cause of 934 deaths in 2003, a similar number linked to MRSA.

The Department of Health also released figures for the number of cases of GRE, a bug which can cause wound infections and occasionally blood poisoning.”

Although hard to treat it is not particularly virulent compared to other hospital infections, with just 620 cases.

Chief nursing officer Christine Beasley said some of the rise in infections was down to better reporting.

”This is largely due to the fact that medical care advances were keeping people alive for longer, making them more susceptible to bugs.

"The immune system does not work as well and, therefore, people are more vulnerable.”

C. difficile will now be included in the government programme to fight MRSA.

C. difficile usually affects the elderly, although young people have been affected.

This infection can prove fatal if antibiotic treatment fails to kill all the spores in the gut.

It is also very difficult to eradicate from the ward environment, which means it is easy for other patients to become infected.

The spores of C. difficile cannot be destroyed by hand gels, whereas MRSA can.

Experts have said staff must use soap and water to get rid of the bug.

The BBC also reports that hospital wards must be cleaned using more powerful disinfectants than usual to eradicate the bug.

Professor Mark Willcox is a consultant medical microbiologist who works on a C. difficile standards group that reported to the Department of Health.

Professor Willcox told the BBC "The most worrying concern is not so much how many cases we are having, but this new strain which appeared first in Canada about 2 or 3 years ago.”

"It appears to cause an excess number of cases when it occurs in a hospital, but the particularly worrisome thing is that it causes more severe cases - patients can be very ill with this strain."

BBC News 2005, 26 August, 09:29 GMT
29 August 2005

Go to top of page Email this page Email this page to a colleague

 17 November 2017 
Food elimination diets for treatment of adults with eosinophilic esophagitis
 17 November 2017 
PPI use and cognitive function in women
 17 November 2017 
Predicting microscopic colitis
 16 November 2017 
NAFLD-hepatocellular carcinoma and survival after orthotopic liver transplant
 16 November 2017 
Prepregnancy obesity and severe maternal morbidity
 16 November 2017 
Celiac disease screening in adult first-degree relatives
 15 November 2017 
Breastfeeding and the risk of IBD
 15 November 2017 
Medication nonadherence and health care costs
 15 November 2017 
Predicting recurrence after curative rectal cancer surgery
 14 November 2017 
HBV/HCV coinfection and cirrhosis
 14 November 2017 
Sexual dysfunction after rectal cancer surgery
 14 November 2017 
Eosinophilic gastroenteritis and colitis
 13 November 2017 
GI bleeding in patients taking non–vitamin K antagonist oral anticoagulants
 13 November 2017 
Genetic polymorphisms, fatty acids and ulcerative colitis
 13 November 2017 
Flares after immunomodulator withdrawal in Crohn's
 10 November 2017 
Thiopurines vs TNF and lymphoma risk in IBD
 10 November 2017 
Drug monitoring of anti-tumour necrosis factor therapy in IBD
 10 November 2017 
Treatment decisions for older patients with colorectal cancer
 09 November 2017 
Quality standards in upper gastrointestinal endoscopy
 09 November 2017 
Irradiated rectal cancer and chemoradiotherapy
 09 November 2017 
Environmental factors and IBD
 08 November 2017 
Prophylaxis of spontaneous bacterial peritonitis
 08 November 2017 
Socioeconomic characteristics in diverticular disease
 08 November 2017 
Optimal management of postoperative Crohn's disease
 07 November 2017 
Community Screening for Helicobacter pylori
 07 November 2017 
Early readmission in IBD patients
 07 November 2017 
Mesocolic excision for colon cancer
 06 November 2017 
Food elimination diet for children with eosinophilic esophagitis
 06 November 2017 
Biologic agents and obesity in children with IBD
 06 November 2017 
Liver cancer burden despite extensive use of antiviral agents
 03 November 2017 
Statins and mortality in chronic viral hepatitis
 03 November 2017 
Propofol for outpatient colonoscopy
 03 November 2017 
Asthma and IBD development
 02 November 2017 
Diverticulitis and emergency department burden
 02 November 2017 
Rural residence and risk of IBD
 02 November 2017 
Sexual functioning in Hep C
 01 November 2017 
Heartburn relief in adolescents with GERD
 01 November 2017 
Barriers to hepatitis C treatment
 01 November 2017 
Autoimmune pancreatitis in children
 31 October 2017 
Surveillance in ulcerative colitis and Crohn’s disease
 31 October 2017 
Endoscopic indices of disease activity for Crohn’s
 31 October 2017 
Follow-up of positive results on fecal blood tests
 30 October 2017 
Local recurrence after curative rectal cancer surgery
 30 October 2017 
Low-flow ascites pump in refractory cirrhosis
 30 October 2017 
Medical therapy of patients with pediatric-onset IBD
 27 October 2017 
NAFLD in advanced fibrosis in the USA
 27 October 2017 
Early readmission in cirrhosis after bacterial infections
 26 October 2017 
Predicting response to anti-TNF therapy in Crohn's
 26 October 2017 
Conversion to open laparotomy in rectal cancer
 25 October 2017 
Conversion of colonoscopy to sigmoidoscopy
 25 October 2017 
Fecal microbiota transplantation
 25 October 2017 
Rifaximin and survival in hepatic encephalopathy
 24 October 2017 
Eosinophilic esophagitis with swallowed topical corticosteroids
 24 October 2017 
Meta-analysis in nutritiona research
 23 October 2017 
NAFLD-related hepatocellular carcinoma in liver resection
 23 October 2017 
Outcome of hepatic sarcoidosis
 20 October 2017 
Hospital readmissions reduction program
 20 October 2017 
Conversion of planned colonoscopy to sigmoidoscopy
 19 October 2017 
Fecal immunochemical tests in colorectal cancer screening
 19 October 2017 
Current management of chylous ascites

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us